LMR Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,700
Closed -$3.72M 1710
2025
Q4
$3.72M Sell
38,700
-37,700
-49% -$3.66M 0.01% 653
2025
Q3
$7.28M Sell
76,400
-1,300
-2% -$120K 0.03% 420
2025
Q2
$6.77M Buy
77,700
+4,300
+6% +$365K 0.05% 371
2025
Q1
$6.6M Buy
+73,400
New +$6.57M 0.06% 339
2024
Q4
Sell
-75,600
Closed -$6.81M 1452
2024
Q3
$6.81M Hold
75,600
0.05% 294
2024
Q2
$5.95M Hold
75,600
0.05% 291
2024
Q1
$6.59M Hold
75,600
0.07% 253
2023
Q4
$6.23M Buy
+75,600
New +$5.76M 0.07% 265

Other funds holding MDT

LMR Partners's MDT Position: Q2 2026 in Review

LMR Partners increased its Medtronic (MDT) stake by 1,493% in Q2 2026, buying an estimated $23.3M and bringing the position to 308,551 shares worth $24.1M. The position accounts for 0.09% of the portfolio, ranked #201.

LMR Partners first reported a position in MDT in Q1 2015 and has held it in 24 quarters since. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LMR Partners held 308,551 shares of Medtronic worth $24.1M as of Q2 2026.
  • LMR Partners bought 289,178 Medtronic shares in Q2 2026, an estimated $23.3M.
  • Medtronic made up 0.09% of LMR Partners's portfolio in Q2 2026, its #201 holding.
  • LMR Partners first reported a position in Medtronic in Q1 2015 and has held it in 24 quarters since.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.